Kyme Pierre has filed 4 insider transactions across 1 company since February 2025.
Most recent transaction: a tax payment of 1030 shares of Armata Pharmaceuticals, Inc. ($ARMP) on March 14, 2026.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 14, 2026 | Armata Pharmaceuticals, Inc. | $ARMP | Kyme Pierre | Chief Business Officer | F | Common Stock | 1030 | $10.54 | 9,461.0000 | 36,226,285 | 9.82% | 0.00% |
| March 9, 2026 | Armata Pharmaceuticals, Inc. | $ARMP | Kyme Pierre | Chief Business Officer | A | Stock Options (Right to Buy) | 183142 | $0.00 | 183,142.0000 | 36,226,285 | 9999.99% | 0.51% |
| March 14, 2025 | Armata Pharmaceuticals, Inc. | $ARMP | Kyme Pierre | Chief Business Officer | F | Common Stock | 1027 | $1.95 | 10,491.0000 | 59,059,971 | 8.92% | 0.00% |
| Feb. 5, 2025 | Armata Pharmaceuticals, Inc. | $ARMP | Kyme Pierre | Chief Business Officer | A | Stock Options (Right to Buy) | 100000 | $0.00 | 100,000.0000 | 59,059,971 | 9999.99% | 0.17% |